Erratum To: Elafin Is Downregulated During Breast and Ovarian Tumorigenesis but Its Residual Expression Predicts Recurrence

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-015-0572-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Estrogen Receptor Signaling Is Reprogrammed During Breast Tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence

PLoS ONE
Multidisciplinary
2012English

Expression of Nicotinamide Phosphoribosyltransferase-Influenced Genes Predicts Recurrence-Free Survival in Lung and Breast Cancers

Scientific Reports
Multidisciplinary
2014English

Urocortin Expression Is Downregulated in Human Endometrial Carcinoma

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2006English

A Random Forest Classifier Predicts Recurrence Risk in Patients With Ovarian Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Downregulated Expression of Hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Elafin, an Inhibitor of Elastase, Is a Prognostic Indicator in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2013English

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

CD-34 Expression by Cultured Human Keratocytes Is Downregulated During Myofibroblast Differentiation Induced by TGF-β1

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy